Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy
To access this article, please choose from the options below
PII: S0145-2126(09)00111-8
doi:10.1016/j.leukres.2009.03.004
© 2009 Elsevier Ltd. All rights reserved.
